We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 403

Unpacking Patent Box: Who’s claiming relief in the UK?
  • Griffith Hack
  • Australia, OECD, United Kingdom
  • November 18 2016

The first statistics showing how the UK’s patent box is being utilised by businesses have now been released


Pfizer’s LYRICA patent sufficient, valid and infringed in Australia (but not in the UK)
  • Davies Collison Cave
  • Australia, United Kingdom
  • November 28 2016

In the recent decision of Apotex Pty Ltd v Warner-Lambert Company LLC (No 2) 2016 FCA 1238, the Federal Court has upheld the validity of Pfizer's


Reforms to be made to UK groundless threats rules
  • Gilbert + Tobin
  • Australia, United Kingdom
  • March 5 2015

The UK government has outlined measures to reform the groundless threats regime, responding to proposals published by the Law Commission last year


Look before you leap: seeking to enforce your pharmaceutical patent may lead to unintended consequences
  • FPA Patent Attorneys
  • Australia, United Kingdom, USA
  • January 11 2016

It may not be just generic manufacturers seeking compensation when their product launch is found to be delayed by an originator wielding what is


Latest Options for Fast-Tracking Clean Technology Patent Applications
  • Sterne Kessler Goldstein & Fox
  • Australia, Brazil, Canada, Israel, Japan, Taiwan, United Kingdom, USA
  • December 17 2015

The grant of a patent can be delayed by years due to backlogs at patent offices around the world. However, recognizing the urgent need to address


Survey of the Safe Harbor in the United States and Europe
  • Fish & Richardson PC
  • Australia, European Union, United Kingdom, USA
  • December 7 2016

On October 3, 2016, the United States Supreme Court denied Amphastar Pharmaceutical's petition for certiorari regarding the so-called "safe harbor,"


Could the courts compel prescribers and dispensers of medicines to help big pharma fight generics?
  • Watermark Patent & Trade Marks Attorneys
  • Australia, United Kingdom
  • May 6 2015

A recent UK court ruling broke new ground in ordering an official health body to issue guidelines on prescribing a generic drug. Could the same thing


New global initiatives to accelerate examination of cleantech patent applications
  • Sterne Kessler Goldstein & Fox
  • Australia, Brazil, Canada, China, Israel, Japan, South Korea, United Kingdom, USA
  • August 6 2012

In an effort to promote the development and commercialization of technologies that conserve natural resources or reduce negative environmental impact, patent offices around the world have adopted programs to expedite the examination of patent applications pertaining to clean technologies


Australian High Court declares methods of medical treatment are patentable
  • Marks & Clerk
  • Australia, United Kingdom
  • December 16 2013

In Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd 2013 HCA 50 (4 December 2013), the matter before the High Court of Australia involved a


A single application and examination process for Australia and New Zealand?
  • Marks & Clerk
  • Australia, New Zealand, United Kingdom
  • December 16 2013

The New Zealand Government has released a discussion document on proposed changes to its Patents Regulations which provide for the implementation of